Aequitron Receives FDA OK on Phototherapy Light

Aequitron Medical said it received Food & Drug Administration clearance to market its Model 7100 phototherapy light, which is designed to speed recovery from newborn jaundice.

The company said an estimated 10% of newborn infants have abnormaly high bilirubin levels and require light therapy, necessitating exended hospital stays until the danger of central nervous system toxicity has passed. The company said the product is portable.